Statins in the Indian pharmaceutical market
| Statins market | Volumes in billion SUs (%) | Values in INR billions (%) | ||||||
| 2012 | 2013 | 2014 | 2015 | 2012 | 2013 | 2014 | 2015 | |
| Overall statins market (share in the Indian pharmaceutical market) | 2.50 (0.50) | 2.81 (0.56) | 3.15 (0.60) | 3.56 (0.63) | 15.47 (2.16) | 16.92 (2.14) | 19.41 (2.20) | 22.90 (2.25) |
| Fixed Dose Combinations (share in statins market) | 0.94 (37.56) | 1.14 (40.44) | 1.31 (41.76) | 1.55 (43.40) | 4.56 (29.46) | 5.21 (30.79) | 6.48 (33.40) | 7.92 (34.56) |
| Plain formulations (share in statins market) | 1.56 (62.44) | 1.67 (59.56) | 1.83 (58.24) | 2.02 (56.60) | 10.91 (70.54) | 11.71 (69.21) | 12.93 (66.60) | 14.99 (65.44) |
| Total market | 504 357.87 | 504 757.49 | 523 098.93 | 563 619.26 | 715 163.62 | 788 943.16 | 882 423.34 | 1 015 741.19 |
INR refers to Indian national rupee.
SUs, standard units.